Aziyo Biologics, Inc.
880 Harbour Way S
About Aziyo Biologics, Inc.
Aziyo Biologics was created by HighCape Partners and Tissue Banks International with the mission of restoring health and mobility to the greatest number of patients. Our vision is to impact healthcare through innovation of new solutions that expand the possibilities of regenerative medicine.
Executive Chairman & Interim CEO: Kevin Rakin
COO: Michelle LeRoux William, PhD
VP, Technical Services: Erica Elchin
Please click here for Aziyo Biologics' products.
51 articles with Aziyo Biologics, Inc.
RTI Surgical® and Aziyo® Biologics Announce Exclusive Agreement to Distribute ViBone® for Spine and Other Orthopedic Procedures
Agreement will expand availability of ViBone, a next generation cellular bone matrix product
ViBone viable bone matrix in GraftGun to be marketed for minimally invasive spine and orthopedic surgery
Seasoned leader brings a wealth of experience in commercial and business development
Aziyo Biologics, Inc., a fully integrated regenerative medicine company, today announced that it has entered into a US co-distribution agreement for its CanGaroo® Bio Envelope with BIOTRONIK, Inc., a global leader in cardio- and endovascular medical technology.
Innovative processing and delivery characteristics provide significant improvement versus other available products
Aziyo and Cook Biotech Announce Further Expansion of the Bio Envelope Franchise into Additional Markets
Aziyo Biologics, Inc. and Cook Biotech Inc. today announced the expansion of the Aziyo Bio Envelope franchise by entering into additional exclusive global license agreements expanding the applications for the Bio Envelope product into the field of neuromodulation.
Aziyo Presents Positive Initial Data From Clinical Study of Biologic Extracellular Matrix Scaffold for Femoral Arterial Reconstruction
There were no device-related adverse events or infections and primary patency was maintained in 97.6% of procedures.